ID AADAT_MOUSE Reviewed; 425 AA. AC Q9WVM8; DT 13-APR-2004, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1999, sequence version 1. DT 02-SEP-2026, entry version 159. DE RecName: Full=Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial {ECO:0000305}; DE Short=KAT/AadAT; DE AltName: Full=2-aminoadipate aminotransferase; DE AltName: Full=2-aminoadipate transaminase; DE EC=2.6.1.39 {ECO:0000250|UniProtKB:Q8N5Z0}; DE AltName: Full=Alpha-aminoadipate aminotransferase; DE Short=AadAT; DE AltName: Full=Glycine transaminase AADAT {ECO:0000250|UniProtKB:Q8N5Z0}; DE EC=2.6.1.4 {ECO:0000250|UniProtKB:Q8N5Z0}; DE AltName: Full=Kynurenine aminotransferase II; DE AltName: Full=Kynurenine--glyoxylate transaminase AADAT {ECO:0000250|UniProtKB:Q8N5Z0}; DE EC=2.6.1.63 {ECO:0000250|UniProtKB:Q8N5Z0}; DE AltName: Full=Kynurenine--oxoglutarate aminotransferase II; DE AltName: Full=Kynurenine--oxoglutarate transaminase 2; DE EC=2.6.1.7 {ECO:0000250|UniProtKB:Q8N5Z0}; DE AltName: Full=Kynurenine--oxoglutarate transaminase II; DE AltName: Full=Methionine--glyoxylate transaminase AADAT {ECO:0000250|UniProtKB:Q8N5Z0}; DE EC=2.6.1.73 {ECO:0000250|UniProtKB:Q8N5Z0}; DE Flags: Precursor; GN Name=Aadat {ECO:0000312|MGI:MGI:1345167}; Synonyms=Kat2; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY. RC STRAIN=129/SvJ; RX PubMed=10441733; DOI=10.1007/s003359901102; RA Yu P., Mosbrook D.M., Tagle D.A.; RT "Genomic organization and expression analysis of mouse kynurenine RT aminotransferase II, a possible factor in the pathophysiology of RT Huntington's disease."; RL Mamm. Genome 10:845-852(1999). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=C57BL/6J; TISSUE=Kidney; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Liver; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-40, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Kidney, and Liver; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [5] RP SUCCINYLATION [LARGE SCALE ANALYSIS] AT LYS-172; LYS-263; LYS-339 AND RP LYS-367, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001; RA Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y., RA Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.; RT "SIRT5-mediated lysine desuccinylation impacts diverse metabolic RT pathways."; RL Mol. Cell 50:919-930(2013). RN [6] RP ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-69; LYS-179; LYS-263; LYS-339; RP LYS-351; LYS-367 AND LYS-422, AND IDENTIFICATION BY MASS SPECTROMETRY RP [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=23576753; DOI=10.1073/pnas.1302961110; RA Rardin M.J., Newman J.C., Held J.M., Cusack M.P., Sorensen D.J., Li B., RA Schilling B., Mooney S.D., Kahn C.R., Verdin E., Gibson B.W.; RT "Label-free quantitative proteomics of the lysine acetylome in mitochondria RT identifies substrates of SIRT3 in metabolic pathways."; RL Proc. Natl. Acad. Sci. U.S.A. 110:6601-6606(2013). CC -!- FUNCTION: Transaminase with broad substrate specificity. Has CC transaminase activity towards aminoadipate, kynurenine, methionine and CC glutamate. Shows activity also towards tryptophan, aspartate and CC hydroxykynurenine. Accepts a variety of oxo-acids as amino-group CC acceptors, with a preference for 2-oxoglutarate, 2-oxocaproic acid, CC phenylpyruvate and alpha-oxo-gamma-methiol butyric acid. Can also use CC glyoxylate as amino-group acceptor (in vitro) (By similarity). CC {ECO:0000250|UniProtKB:Q8N5Z0}. CC -!- CATALYTIC ACTIVITY: CC Reaction=L-kynurenine + 2-oxoglutarate = kynurenate + L-glutamate + CC H2O; Xref=Rhea:RHEA:65560, ChEBI:CHEBI:15377, ChEBI:CHEBI:16810, CC ChEBI:CHEBI:29985, ChEBI:CHEBI:57959, ChEBI:CHEBI:58454; EC=2.6.1.7; CC Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:65561; CC Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC -!- CATALYTIC ACTIVITY: CC Reaction=L-2-aminoadipate + 2-oxoglutarate = 2-oxoadipate + L- CC glutamate; Xref=Rhea:RHEA:12601, ChEBI:CHEBI:16810, CC ChEBI:CHEBI:29985, ChEBI:CHEBI:57499, ChEBI:CHEBI:58672; EC=2.6.1.39; CC Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC -!- CATALYTIC ACTIVITY: CC Reaction=glycine + 2-oxoglutarate = glyoxylate + L-glutamate; CC Xref=Rhea:RHEA:14089, ChEBI:CHEBI:16810, ChEBI:CHEBI:29985, CC ChEBI:CHEBI:36655, ChEBI:CHEBI:57305; EC=2.6.1.4; CC Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC -!- CATALYTIC ACTIVITY: CC Reaction=L-kynurenine + glyoxylate = kynurenate + glycine + H2O; CC Xref=Rhea:RHEA:65896, ChEBI:CHEBI:15377, ChEBI:CHEBI:36655, CC ChEBI:CHEBI:57305, ChEBI:CHEBI:57959, ChEBI:CHEBI:58454; EC=2.6.1.63; CC Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:65897; CC Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC -!- CATALYTIC ACTIVITY: CC Reaction=3-hydroxy-L-kynurenine + glyoxylate = xanthurenate + glycine + CC H2O; Xref=Rhea:RHEA:65900, ChEBI:CHEBI:15377, ChEBI:CHEBI:36655, CC ChEBI:CHEBI:57305, ChEBI:CHEBI:58125, ChEBI:CHEBI:71201; EC=2.6.1.63; CC Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC -!- CATALYTIC ACTIVITY: CC Reaction=2-oxohexanoate + L-kynurenine = L-2-aminohexanoate + CC kynurenate + H2O; Xref=Rhea:RHEA:66060, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:35177, ChEBI:CHEBI:57959, ChEBI:CHEBI:58454, CC ChEBI:CHEBI:58455; Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66061; CC Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC -!- CATALYTIC ACTIVITY: CC Reaction=3-phenylpyruvate + L-kynurenine = kynurenate + L-phenylalanine CC + H2O; Xref=Rhea:RHEA:66092, ChEBI:CHEBI:15377, ChEBI:CHEBI:18005, CC ChEBI:CHEBI:57959, ChEBI:CHEBI:58095, ChEBI:CHEBI:58454; CC Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66093; CC Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC -!- CATALYTIC ACTIVITY: CC Reaction=4-methylsulfanyl-2-oxobutanoate + L-kynurenine = kynurenate + CC L-methionine + H2O; Xref=Rhea:RHEA:69096, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:16723, ChEBI:CHEBI:57844, ChEBI:CHEBI:57959, CC ChEBI:CHEBI:58454; Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:69097; CC Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC -!- CATALYTIC ACTIVITY: CC Reaction=2-oxo-3-sulfanylpropanoate + L-kynurenine = kynurenate + L- CC cysteine + H2O; Xref=Rhea:RHEA:69104, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:35235, ChEBI:CHEBI:57678, ChEBI:CHEBI:57959, CC ChEBI:CHEBI:58454; Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:69105; CC Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC -!- CATALYTIC ACTIVITY: CC Reaction=indole-3-pyruvate + L-kynurenine = kynurenate + L-tryptophan + CC H2O; Xref=Rhea:RHEA:66052, ChEBI:CHEBI:15377, ChEBI:CHEBI:17640, CC ChEBI:CHEBI:57912, ChEBI:CHEBI:57959, ChEBI:CHEBI:58454; CC Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66053; CC Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC -!- CATALYTIC ACTIVITY: CC Reaction=2-oxopentanoate + L-kynurenine = L-2-aminopentanoate + CC kynurenate + H2O; Xref=Rhea:RHEA:66076, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:28644, ChEBI:CHEBI:57959, ChEBI:CHEBI:58441, CC ChEBI:CHEBI:58454; Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66077; CC Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC -!- CATALYTIC ACTIVITY: CC Reaction=4-methyl-2-oxopentanoate + L-kynurenine = kynurenate + L- CC leucine + H2O; Xref=Rhea:RHEA:66068, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:17865, ChEBI:CHEBI:57427, ChEBI:CHEBI:57959, CC ChEBI:CHEBI:58454; Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66069; CC Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC -!- CATALYTIC ACTIVITY: CC Reaction=glyoxylate + L-methionine = 4-methylsulfanyl-2-oxobutanoate + CC glycine; Xref=Rhea:RHEA:22884, ChEBI:CHEBI:16723, ChEBI:CHEBI:36655, CC ChEBI:CHEBI:57305, ChEBI:CHEBI:57844; EC=2.6.1.73; CC Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC -!- CATALYTIC ACTIVITY: CC Reaction=L-2-aminoadipate + glyoxylate = 2-oxoadipate + glycine; CC Xref=Rhea:RHEA:69112, ChEBI:CHEBI:36655, ChEBI:CHEBI:57305, CC ChEBI:CHEBI:57499, ChEBI:CHEBI:58672; CC Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:69113; CC Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC -!- CATALYTIC ACTIVITY: CC Reaction=L-tyrosine + glyoxylate = 3-(4-hydroxyphenyl)pyruvate + CC glycine; Xref=Rhea:RHEA:69116, ChEBI:CHEBI:36242, ChEBI:CHEBI:36655, CC ChEBI:CHEBI:57305, ChEBI:CHEBI:58315; CC Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC -!- CATALYTIC ACTIVITY: CC Reaction=glyoxylate + L-phenylalanine = 3-phenylpyruvate + glycine; CC Xref=Rhea:RHEA:69120, ChEBI:CHEBI:18005, ChEBI:CHEBI:36655, CC ChEBI:CHEBI:57305, ChEBI:CHEBI:58095; CC Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC -!- CATALYTIC ACTIVITY: CC Reaction=L-tryptophan + glyoxylate = indole-3-pyruvate + glycine; CC Xref=Rhea:RHEA:69124, ChEBI:CHEBI:17640, ChEBI:CHEBI:36655, CC ChEBI:CHEBI:57305, ChEBI:CHEBI:57912; CC Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC -!- CATALYTIC ACTIVITY: CC Reaction=L-leucine + glyoxylate = 4-methyl-2-oxopentanoate + glycine; CC Xref=Rhea:RHEA:69128, ChEBI:CHEBI:17865, ChEBI:CHEBI:36655, CC ChEBI:CHEBI:57305, ChEBI:CHEBI:57427; CC Evidence={ECO:0000250|UniProtKB:Q8N5Z0}; CC -!- CATALYTIC ACTIVITY: CC Reaction=2-oxobutanoate + L-kynurenine = (2S)-2-aminobutanoate + CC kynurenate + H2O; Xref=Rhea:RHEA:66044, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:16763, ChEBI:CHEBI:57959, ChEBI:CHEBI:58454, CC ChEBI:CHEBI:74359; Evidence={ECO:0000250|UniProtKB:Q64602}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66045; CC Evidence={ECO:0000250|UniProtKB:Q64602}; CC -!- CATALYTIC ACTIVITY: CC Reaction=2-oxoadipate + L-kynurenine = L-2-aminoadipate + kynurenate + CC H2O; Xref=Rhea:RHEA:70047, ChEBI:CHEBI:15377, ChEBI:CHEBI:57499, CC ChEBI:CHEBI:57959, ChEBI:CHEBI:58454, ChEBI:CHEBI:58672; CC Evidence={ECO:0000250|UniProtKB:Q64602}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:70048; CC Evidence={ECO:0000250|UniProtKB:Q64602}; CC -!- COFACTOR: CC Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326; CC -!- PATHWAY: Amino-acid degradation; L-lysine degradation via saccharopine CC pathway; glutaryl-CoA from L-lysine: step 4/6. CC -!- SUBUNIT: Homodimer. {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000305}. CC -!- TISSUE SPECIFICITY: Expressed mainly in kidney and to a lesser amount CC in liver and brain. {ECO:0000269|PubMed:10441733}. CC -!- SIMILARITY: Belongs to the class-I pyridoxal-phosphate-dependent CC aminotransferase family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF072376; AAD39680.1; -; mRNA. DR EMBL; AK075578; BAC35833.1; -; mRNA. DR EMBL; BC012637; AAH12637.1; -; mRNA. DR CCDS; CCDS22320.1; -. DR RefSeq; NP_035964.1; NM_011834.2. DR AlphaFoldDB; Q9WVM8; -. DR SMR; Q9WVM8; -. DR FunCoup; Q9WVM8; 691. DR STRING; 10090.ENSMUSP00000078436; -. DR iPTMnet; Q9WVM8; -. DR PhosphoSitePlus; Q9WVM8; -. DR SwissPalm; Q9WVM8; -. DR jPOST; Q9WVM8; -. DR PaxDb; 10090-ENSMUSP00000078436; -. DR ProteomicsDB; 285893; -. DR Antibodypedia; 17143; 329 antibodies from 35 providers. DR DNASU; 23923; -. DR Ensembl; ENSMUST00000079472.4; ENSMUSP00000078436.3; ENSMUSG00000057228.7. DR GeneID; 23923; -. DR KEGG; mmu:23923; -. DR UCSC; uc009lte.1; mouse. DR AGR; MGI:1345167; -. DR CTD; 51166; -. DR MGI; MGI:1345167; Aadat. DR VEuPathDB; HostDB:ENSMUSG00000057228; -. DR eggNOG; KOG0634; Eukaryota. DR GeneTree; ENSGT00390000004594; -. DR HOGENOM; CLU_017584_0_6_1; -. DR InParanoid; Q9WVM8; -. DR OMA; FMPGEPF; -. DR PhylomeDB; Q9WVM8; -. DR BRENDA; 2.6.1.39; 3474. DR BRENDA; 2.6.1.7; 3474. DR Reactome; R-MMU-71064; Lysine catabolism. DR Reactome; R-MMU-71240; Tryptophan catabolism. DR UniPathway; UPA00868; UER00838. DR BioGRID-ORCS; 23923; 3 hits in 77 CRISPR screens. DR PRO; PR:Q9WVM8; -. DR Proteomes; UP000000589; Chromosome 8. DR RNAct; Q9WVM8; protein. DR Bgee; ENSMUSG00000057228; Expressed in right kidney and 69 other cell types or tissues. DR ExpressionAtlas; Q9WVM8; baseline and differential. DR GO; GO:0005829; C:cytosol; ISO:GO_Central. DR GO; GO:0005759; C:mitochondrial matrix; ISO:GO_Central. DR GO; GO:0005739; C:mitochondrion; HDA:MGI. DR GO; GO:0047313; F:aromatic-amino-acid:glyoxylate transaminase activity; IEA:RHEA. DR GO; GO:0047958; F:glycine:2-oxoglutarate transaminase activity; ISS:UniProtKB. DR GO; GO:0047536; F:L-2-aminoadipate:2-oxoglutarate transaminase activity; IDA:MGI. DR GO; GO:0016212; F:L-kynurenine:2-oxoglutarate transaminase activity; ISS:UniProtKB. DR GO; GO:0047315; F:L-kynurenine:glyoxylate transaminase activity; ISS:UniProtKB. DR GO; GO:0050094; F:L-methionine:glyoxylate transaminase activity; ISS:UniProtKB. DR GO; GO:0042803; F:protein homodimerization activity; ISO:GO_Central. DR GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro. DR GO; GO:0006103; P:2-oxoglutarate metabolic process; ISO:GO_Central. DR GO; GO:1901606; P:alpha-amino acid catabolic process; IGI:MGI. DR GO; GO:1901605; P:alpha-amino acid metabolic process; IBA:GO_Central. DR GO; GO:0009063; P:amino acid catabolic process; IGI:MGI. DR GO; GO:0006536; P:glutamate metabolic process; ISO:GO_Central. DR GO; GO:0019477; P:L-lysine catabolic process; IGI:MGI. DR CDD; cd00609; AAT_like; 1. DR FunFam; 3.40.640.10:FF:000071; Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial; 1. DR FunFam; 3.90.1150.10:FF:000166; Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial; 1. DR Gene3D; 3.40.640.10; Type I PLP-dependent aspartate aminotransferase-like (Major domain); 1. DR InterPro; IPR004839; Aminotransferase_I/II_large. DR InterPro; IPR050859; Class-I_PLP-dep_aminotransf. DR InterPro; IPR015424; PyrdxlP-dep_Trfase. DR InterPro; IPR015421; PyrdxlP-dep_Trfase_major. DR PANTHER; PTHR42790; AMINOTRANSFERASE; 1. DR PANTHER; PTHR42790:SF19; KYNURENINE_ALPHA-AMINOADIPATE AMINOTRANSFERASE, MITOCHONDRIAL; 1. DR Pfam; PF00155; Aminotran_1_2; 1. DR SUPFAM; SSF53383; PLP-dependent transferases; 1. PE 1: Evidence at protein level; KW Acetylation; Aminotransferase; Mitochondrion; Phosphoprotein; KW Pyridoxal phosphate; Reference proteome; Transferase; Transit peptide. FT TRANSIT 1..29 FT /note="Mitochondrion" FT /evidence="ECO:0000255" FT CHAIN 30..425 FT /note="Kynurenine/alpha-aminoadipate aminotransferase, FT mitochondrial" FT /id="PRO_0000020603" FT BINDING 20 FT /ligand="substrate" FT /evidence="ECO:0000250" FT BINDING 74 FT /ligand="substrate" FT /evidence="ECO:0000250" FT BINDING 202 FT /ligand="substrate" FT /evidence="ECO:0000250" FT BINDING 399 FT /ligand="substrate" FT /evidence="ECO:0000250" FT MOD_RES 40 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 69 FT /note="N6-acetyllysine" FT /evidence="ECO:0007744|PubMed:23576753" FT MOD_RES 172 FT /note="N6-succinyllysine" FT /evidence="ECO:0007744|PubMed:23806337" FT MOD_RES 179 FT /note="N6-acetyllysine" FT /evidence="ECO:0007744|PubMed:23576753" FT MOD_RES 263 FT /note="N6-(pyridoxal phosphate)lysine; alternate" FT /evidence="ECO:0000250" FT MOD_RES 263 FT /note="N6-acetyllysine; alternate" FT /evidence="ECO:0007744|PubMed:23576753" FT MOD_RES 263 FT /note="N6-succinyllysine; alternate" FT /evidence="ECO:0007744|PubMed:23806337" FT MOD_RES 339 FT /note="N6-acetyllysine; alternate" FT /evidence="ECO:0007744|PubMed:23576753" FT MOD_RES 339 FT /note="N6-succinyllysine; alternate" FT /evidence="ECO:0007744|PubMed:23806337" FT MOD_RES 351 FT /note="N6-acetyllysine" FT /evidence="ECO:0007744|PubMed:23576753" FT MOD_RES 367 FT /note="N6-acetyllysine; alternate" FT /evidence="ECO:0007744|PubMed:23576753" FT MOD_RES 367 FT /note="N6-succinyllysine; alternate" FT /evidence="ECO:0007744|PubMed:23806337" FT MOD_RES 422 FT /note="N6-acetyllysine" FT /evidence="ECO:0007744|PubMed:23576753" SQ SEQUENCE 425 AA; 47598 MW; E3A6711CFE96D77E CRC64; MNYSRFLTAT SLARKPSPIR TTADILSKAP KTLISLAPGS PNPSMFPFKS AAFTVENGST IRFEDDLIKR ALQYSPSYGI PELLSWLKQF QVKLHNPPTV NYPPNQGQMD LCITSGCQDG LCKAFEMLIN PGDTILVNEP LFPGTLYAMK PLGCNIINVP SDEHGIIPEG LKKILSQWKP EDSKDPTKKT PKFLYTVPNG NNPTGNSLTG DRKKEIYELA RKYDFLIIED DPYYFLQFSK PWEPTFLSMD VDGRVIRADT FSKTVSSGLR VGFMTGPKTL IQNIVLHTQV SSVHACTLSQ LMILQLLHQW GEEGFLAHID RTIDFYKNQR DSILAAADKW LRGLAEWHVP KAGMFLWIKV KGISDTKQLI EEKAIEREVL LVPGNGFFID GSAPTSFFRA SFSLATPAQM DTAFQRLAQL IKESL //